The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review

被引：0
|
作者：
Jonathan Adachi
Niall Lynch
Hans Middelhoven
Manjit Hunjan
Warren Cowell
机构：
[1] McMaster University,Health Outcomes Research
[2] Global Health Outcomes,Healthcare Management
[3] Economic Value Strategy,undefined
[4] GlaxoSmithKline UK Ltd,undefined
[5] Roche Products Limited,undefined
来源：
BMC Musculoskeletal Disorders | / 8卷
关键词：
Vertebral Fracture; Fracture Risk; Alendronate; Osteoporotic Fracture; Risedronate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review
    Adachi, Jonathan
    Lynch, Niall
    Middelhoven, Hans
    Hunjan, Manjit
    Cowell, Warren
    BMC MUSCULOSKELETAL DISORDERS, 2007, 8 (1)
  • [2] PERSISTENCE WITH BISPHOSPHONATE THERAPY AND RISK OF HIP FRACTURE
    Chodick, G.
    Shalev, V
    Sharon, Y.
    Goldstein, I
    VALUE IN HEALTH, 2011, 14 (03) : A124 - A124
  • [3] The impact of sub optimal compliance and persistence with bisphosphonate therapy on post menopausal osteoporotic fracture risk
    Cowell, W.
    Lynch, N. O.
    Middelhoven, H.
    Hunjan, M.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S120 - S120
  • [4] Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan
    Y.-K. Soong
    K.-S. Tsai
    H.-Y. Huang
    R.-S. Yang
    J.-F. Chen
    P. C.-H. Wu
    K.-E. Huang
    Osteoporosis International, 2013, 24 : 511 - 521
  • [5] THE RISK OF REFRACTURE ASSOCIATED WITH THE COMPLIANCE AND THE PERSISTENCE WITH BISPHOSPHONATE THERAPY IN TAIWAN
    Soong, Y.
    Tsai, K.
    Chen, J.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 279 - 279
  • [6] THE RISK OF REFRACTURE ASSOCIATED WITH THE COMPLIANCE AND THE PERSISTENCE WITH BISPHOSPHONATE THERAPY IN TAIWAN
    Su, Y. J.
    Lin, M. J.
    Tsai, I. C.
    Soong, Y. K.
    VALUE IN HEALTH, 2010, 13 (07) : A557 - A558
  • [7] Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan
    Soong, Y. -K.
    Tsai, K. -S.
    Huang, H. -Y.
    Yang, R. -S.
    Chen, J. -F.
    Wu, P. C. -H.
    Huang, K. -E.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (02) : 511 - 521
  • [8] Improving compliance and persistence with bisphosphonate therapy for osteoporosis
    Emkey, RD
    Ettinger, M
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (04): : 18S - 24S
  • [9] Impact of bisphosphonate compliance on the risk of osteoporotic fracture in France
    Belhassen, Manon
    Cortet, Bernard
    Confavreux, Cyrille B.
    Lamezec, Liliane
    Ginoux, Marine
    Van Ganse, Eric
    ARCHIVES OF OSTEOPOROSIS, 2018, 13 (01)
  • [10] Impact of bisphosphonate compliance on the risk of osteoporotic fracture in France
    Manon Belhassen
    Bernard Cortet
    Cyrille B. Confavreux
    Liliane Lamezec
    Marine Ginoux
    Eric Van Ganse
    Archives of Osteoporosis, 2018, 13
12345